Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2014
05/08/2014WO2014067498A1 Chimeric vaccine antigens against hepatitis c virus
05/08/2014WO2014067011A1 Crystal structures of heterodimeric fc domains
05/08/2014WO2014067002A1 Synthetic lethality and the treatment of cancer
05/08/2014WO2014066939A1 Novel immunotherapeutic molecules and uses thereof
05/08/2014WO2014043484A3 Metabolic remodeling of the tumor microenvironment: migration stimulating factor (msf) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth
05/08/2014WO2014008406A3 The bacterial biofilm matrix as a platform for protein delivery
05/08/2014WO2013081471A3 Facile laboratory method for localising biomolecules to the surface of cells and viruses
05/08/2014WO2013055420A3 Novel clostridium difficile dna vaccine
05/08/2014WO2013049517A3 Therapeutic peptides
05/08/2014WO2013043070A9 Anti-tumor necrosis factor-alpha agents and uses thereof
05/08/2014WO2013040547A3 Compounds and methods of immunization with tumor antigens
05/08/2014WO2013033206A3 Compositions and methods for inhibiting ccl3
05/08/2014WO2013019615A3 Switch costimulatory receptors
05/08/2014WO2013019603A3 Linear expression cassettes and uses thereof
05/08/2014WO2013013013A3 Compositions and methods for producing modified glycoproteins
05/08/2014WO2013012743A3 Methods and compositions for inhibiting staphylococcus agglutination in blood
05/08/2014WO2013006766A3 Formulations that stabilize proteins
05/08/2014WO2013006490A3 Antibodies that specifically bind to tim3
05/08/2014WO2012177481A3 Fibroblast growth factor receptor inhibition for the treatment of disease
05/08/2014WO2012170753A3 Bovine vaccines and methods
05/08/2014WO2012166617A3 Methods, compositions, and kits for the treatment of cancer
05/08/2014WO2012160563A3 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
05/08/2014WO2012138739A3 Compositions and methods for treating cancer
05/08/2014US20140128580 Antibody-drug conjugates and methods
05/08/2014US20140128328 Peptide antagonists of zonulin and methods for use of the same
05/08/2014US20140127301 Adjuvant Incorporation in Immunonanotherapeutics
05/08/2014US20140127298 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
05/08/2014US20140127268 Method for Expanding Monocytes
05/08/2014US20140127267 Fungal-derived carbohydrate-conjugated scaffold
05/08/2014US20140127266 Plant produced vaccine for amebiasis
05/08/2014US20140127265 GUINEA PIG CYTOMEGALOVIRUS (CIDMTR Strain)
05/08/2014US20140127264 Infectious bronchitis virus (ibv) spike protein as subunit vaccine
05/08/2014US20140127263 Augmentation of titer for vaccination in animals
05/08/2014US20140127262 Refrigerator-temperature stable influenza vaccine compositions
05/08/2014US20140127261 Flavivirus Envelope Protein Mutations Affecting Virion Disassembly
05/08/2014US20140127260 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
05/08/2014US20140127259 Compositions and methods for vaccinating cattle
05/08/2014US20140127258 Viral Vector Immunogenic Compositions
05/08/2014US20140127255 Chimeric immunomodulatory compounds and methods of using the same-iv
05/08/2014US20140127254 Transgenic algae for delivering antigens to an animal
05/08/2014US20140127253 Biodegradable particulate formulations
05/08/2014US20140127252 Tularemia-taa/cd40l vaccine
05/08/2014US20140127251 Vaccines for prevention and treatment of tuberculosis
05/08/2014US20140127250 Staphylococcus aureus proteins and nucleic acids
05/08/2014US20140127247 Vaccines for hsv-2
05/08/2014US20140127246 Spanx-b polypeptides and their use
05/08/2014US20140127244 Vaccines for suppressing ige-mediated allergic disease and methods for using the same
05/08/2014US20140127243 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127236 Humanised anti-cd52 antibodies
05/08/2014US20140127233 Pharmaceutical composition for treating ischemic events
05/08/2014US20140127231 p38 MAPK Pathway Inhibitors as Female-Specific Therapeutics
05/08/2014US20140127228 Inhibition of tgfbeta signaling to improve muscle function in cancer
05/08/2014US20140127226 T Cell Regulation
05/08/2014US20140127224 Therapeutic Method
05/08/2014US20140127222 Formulation of human antibodies for treating tnf-alpha associated disorders
05/08/2014US20140127218 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127217 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127215 Clostridium difficile antigens
05/08/2014US20140127214 Natural igm antibodies and inhibitors thereof
05/08/2014US20140127207 Antibodies against epidermal growth factor receptor (egfr) and uses thereof
05/08/2014US20140127202 Antitumour combinations containing a vegf inhibiting agent and irinotecan
05/08/2014US20140127200 Multispecific Antibody Targeting and Multivalency Through Modular Recognition Domains
05/08/2014US20140127199 Compositions and methods for treating or preventing lupus
05/08/2014US20140127198 Antigen Presenting Cell Targeted Anti-Viral Vaccines
05/08/2014US20140127197 Anti-CD22 Antibodies and Immunoconjugates and Methods of Use
05/08/2014US20140127195 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
05/08/2014US20140127194 Combined pharmaceutical compositions for the treatment of tumors
05/08/2014US20140127193 Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
05/08/2014US20140127192 Method for treating osteoporosis
05/08/2014US20140127190 Compositions and methods for the treatment of systemic inflammatory response syndromes
05/08/2014US20140127134 Treatment and prevention of cancer with hmgb1 antagonists
05/08/2014DE102006053385B4 Enterococcus faecalis-Antigen Enterococcus faecalis antigen
05/07/2014EP2728004A2 Bacterial toxin vaccine
05/07/2014EP2728002A1 Heterodimerized polypeptide
05/07/2014EP2727996A1 Treatment of chronic inflammatory respiratory disorders with NP1 inhibitors
05/07/2014EP2727944A1 Depletion of CCR2-positive monocytes for the treatment of inflammatory conditions in the gastrointestinal system
05/07/2014EP2727939A2 VEGF-binding molecules
05/07/2014EP2727937A1 Soluble integrin 4 mutant
05/07/2014EP2727934A1 Fusion proteins with representation of different allergens: vaccine proposal for mite allergies
05/07/2014EP2727602A1 Method for preparation of a high concentration liquid formulation of an antibody
05/07/2014EP2727584A1 Vent gases for use in drying, storing and/or reconstituting biomolecules
05/07/2014EP2726869A2 Somatic mutations in atrx in brain cancer
05/07/2014EP2726612A1 Composition comprising inhibitors of irs-1 and of vegf
05/07/2014EP2726605A2 Peptide
05/07/2014EP2726509A1 Use of anti-cd83 agonist antibodies for treating autoimmune diseases
05/07/2014EP2726505A1 Therapeutic targeting of ficolin-3
05/07/2014EP2726499A1 Epitope and its use of hepatitis b virus surface antigen
05/07/2014EP2726103A2 Anti-properdin antibodies and uses thereof
05/07/2014EP2726102A2 Methods and compositions of protein antigens for the diagnosis and treatment of herpes simplex viruses type 1 and 2
05/07/2014EP2726101A1 Inhibitors of t-cell activation
05/07/2014EP2726100A2 Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers
05/07/2014EP2726099A1 Method for treating metabolic disorders
05/07/2014EP2726098A1 Anti-c-met antibody formulations
05/07/2014EP2726097A2 Herpes virus vaccine and methods of use
05/07/2014EP2726096A1 Canine coronavirus vaccine
05/07/2014EP2726095A1 Combination therapy
05/07/2014EP2726094A2 Therapeutic and diagnostic target
05/07/2014EP2726093A2 Wap domain fusion polypeptides and methods of use thereof
05/07/2014EP2726092A2 Serpin fusion polypeptides and methods of use thereof
05/07/2014EP2726088A1 Predictive biomarker of survival in the treatment of renal cell carcinoma
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 1823